title: Association of blood groups with ovarian reserve and outcome of in vitro fertilization treatment.
abstract: BACKGROUND
  The association between ABO blood groups and ovarian reserve in infertile patients has been a point of controversy.
  
  
  OBJECTIVE
  The aim of this study was to assess the correlation of certain blood groups with ovarian reserve and response to treatment in patients undergoing infertility treatment.
  
  
  METHODS
  Retrospective medical record review.
  
  
  METHODS
  Infertility clinic in the assisted reproductive technology (ART) unit at King Faisal Specialist Hospital and Research Center, Riyadh Saudi Arabia.
  
  
  METHODS
  All patients under 40 years of age who attended the infertility clinic at a tertiary care centre in 2010 and underwent in vitro fertilization (IVF) treatment in 2010 and 2011 were divided into groups according to blood type, and clinical parameters were compared.
  
  
  METHODS
  The association between blood groups and ovarian reserve using day 3 luteinzing hormone (LH) and follicular stimulating hormone (FSH) levels, and antral follical count (AFC).
  
  
  RESULTS
  In 424 patients who underwent 566 IVF cycles, age, LH, FSH and AFC were similar among the different blood groups (P=.9, .1, .5, respectively). with controlled ovarian stimulation, no difference was observed among the four groups in menopausal gonadotrophin (hMG) dose or the duration of stimulation. The number of oocytes retrieved, fertilization rate, cleavage rate, and number of embryos transferred were similar. There was no difference in the cancellation rate or pregnancy rate among the groups.
  
  
  CONCLUSIONS
  There was no significant association between blood type and ovarian reserve or response during IVF treatment in our population.
  
  
  CONCLUSIONS
  Anti-Mullerian hormone levels are best correlated with ovarian reserve testing. Unavailability of AMH levels. Retrospective design.
authors.affiliation: Dr. Khalid Awartani, Department of OB-Gyne Department,, King Faisal Specialist Hospital and Research Center,, MBC 52 Riyadh, 11211, Saudi Arabia, T: +966114423783 F: +9661144237393, kawartani@kfshrc.edu.sa.
authors.forename: Khalid
authors.initials: K
authors.lastname: Awartani
authors.forename: Rahma
authors.initials: R
authors.lastname: Al Ghabshi
authors.forename: Hanan
authors.initials: H
authors.lastname: Al Shankiti
authors.forename: Mohamed
authors.initials: M
authors.lastname: Al Dossari
authors.forename: Serdar
authors.initials: S
authors.lastname: Coskun
mesh_terms: D000017:ABO Blood-Group System; D000328:Adult; D054304:Anti-Mullerian Hormone / Q000097:blood; D004624:Embryo Transfer; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D005640:Follicle Stimulating Hormone / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D065851:Ovarian Reserve / Q000502:physiology*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D018873:Pregnancy Rate; D012189:Retrospective Studies; D012529:Saudi Arabia; D055815:Young Adult
chemical_list: D000017:ABO Blood-Group System; D054304:Anti-Mullerian Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone